Contact

All Stories

  1. SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells

    Article • Scientific Reports, September 2020, Springer Science + Business Media

    Phd Giulio Fracasso

  2. Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I

    Article • Materials, September 2020, MDPI AG

    Phd Giulio Fracasso

  3. Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen

    Article • Scientific Reports, June 2020, Springer Science + Business Media

    Phd Giulio Fracasso

  4. Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer

    Article • Cells, June 2020, MDPI AG

    Phd Giulio Fracasso

  5. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

    Article • Theranostics, January 2019, Ivyspring International Publisher

    Phd Giulio Fracasso

  6. Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

    Article • Nature Communications, December 2018, Springer Science + Business Media

    Phd Giulio Fracasso

  7. Acute Sarcomeric M-Line Disease Associated With ATP Synthase Subunit α Autoantibodies in Ankylosing Spondylitis

    Article • Journal of Neuropathology & Experimental Neurology, September 2018, Oxford University Press (OUP)

    Phd Giulio Fracasso

  8. Nanoaggregates of iron poly-oxo-clusters obtained by laser ablation in aqueous solution of phosphonates

    Article • Journal of Colloid and Interface Science, July 2018, Elsevier

    Phd Giulio Fracasso

  9. The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity

    Article • Journal of Controlled Release, April 2018, Elsevier

    Phd Giulio Fracasso

  10. A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia

    Article • Nanoscale, January 2018, Royal Society of Chemistry

    Phd Giulio Fracasso

  11. Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells

    Article • Nanoscale, January 2018, Royal Society of Chemistry

    Phd Giulio Fracasso

  12. Characterization of site-specifically conjugated monomethyl auristatin E- and duocarmycin-based anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors

    Article • Journal of Nuclear Medicine, November 2017, Society of Nuclear Medicine

    Phd Giulio Fracasso

  13. Pegylated silica nanoparticles: cytotoxicity and macrophage uptake

    Article • Journal of Nanoparticle Research, August 2017, Springer Science + Business Media

    Phd Giulio Fracasso

  14. Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model

    Article • International Journal of Molecular Sciences, July 2017, MDPI AG

    Phd Giulio Fracasso

  15. Liposomes targeting HER-2

    Article • International Journal of Nanomedicine, January 2017, Dove Medical Press

    Dr Antonella Accardo, Phd Giulio Fracasso, Pasquina Marzola

  16. Highly sensitive electrochemiluminescence detection of a prostate cancer biomarker

    Article • Journal of Materials Chemistry B, January 2017, Royal Society of Chemistry

    Phd Giulio Fracasso

  17. Targeted killing of prostate cancer cells using antibody–drug conjugated carbon nanohorns

    Article • Journal of Materials Chemistry B, January 2017, Royal Society of Chemistry

    Phd Giulio Fracasso

  18. Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells “in vitro” and correlating with progression “in vivo”

    Article • Oncotarget, November 2016, Impact Journals, LLC

    Phd Giulio Fracasso

  19. Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness

    Article • Journal of Controlled Release, October 2016, Elsevier

    Phd Giulio Fracasso

  20. Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies

    Article • Cancer Research, May 2016, American Association for Cancer Research (AACR)

    Phd Giulio Fracasso

  21. In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe

    Article • Scientific Reports, March 2016, Nature

    Phd Giulio Fracasso

  22. Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin–Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements

    Article • Biomacromolecules, February 2016, American Chemical Society (ACS)

    Phd Giulio Fracasso

  23. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

    Article • Oncotarget, November 2015, Impact Journals, LLC

    Phd Giulio Fracasso

  24. Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

    Article • Immunology Letters, November 2015, Elsevier

    Phd Giulio Fracasso

  25. Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection

    Article • Biosensors and Bioelectronics, October 2015, Elsevier

    Phd Giulio Fracasso

  26. An electrochemiluminescence-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer

    Article • Faraday Discussions, January 2015, Royal Society of Chemistry

    Luca Prodi, Phd Giulio Fracasso

  27. Laser generated gold nanocorals with broadband plasmon absorption for photothermal applications

    Article • Nanoscale, January 2015, Royal Society of Chemistry

    vincenzo Amendola, Phd Giulio Fracasso

  28. PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models

    Article • PLoS ONE, October 2014, PLOS

    Phd Giulio Fracasso

  29. Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA)

    Article • The Prostate, September 2014, Wiley

    Phd Giulio Fracasso

  30. New 99mTc-radioimmunoconjugates for pancreatic carcinoma detection

    Article • Nuclear Medicine and Biology, August 2014, Elsevier

    Phd Giulio Fracasso

  31. Immunology of RIPs and their Immunotoxins

    Article • April 2014, Wiley

    Phd Giulio Fracasso

  32. Targeting human prostate cancer with111In-labeled D2B IgG, F(ab′)2and Fab fragments in nude mice with PSMA-expressing xenografts

    Article • Contrast Media & Molecular Imaging, April 2014, Wiley

    Phd Giulio Fracasso

  33. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody

    Article • Journal of Nuclear Medicine, April 2014, Society of Nuclear Medicine

    Phd Giulio Fracasso

  34. Magneto‐Plasmonic Au‐Fe Alloy Nanoparticles Designed for Multimodal SERS‐MRI‐CT Imaging

    Article • Small, March 2014, Wiley

    vincenzo Amendola, Phd Giulio Fracasso

  35. Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen

    Article • PLoS ONE, June 2013, PLOS

    Phd Giulio Fracasso

  36. Cloning and characterization of canine prostate-specific membrane antigen

    Article • The Prostate, January 2013, Wiley

    Phd Giulio Fracasso

  37. Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems

    Article • Nanoscale, January 2013, Royal Society of Chemistry

    Phd Giulio Fracasso

  38. Anti-PSMA scFv as theranostic tool for Prostate cancer

    Article • Frontiers in Immunology, January 2013, Frontiers

    Phd Giulio Fracasso

  39. Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor‐Associated Antigens

    Article • Small, August 2012, Wiley

    vincenzo Amendola, Phd Giulio Fracasso

  40. Induction of In Vitro and In Vivo NK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma

    Article • Molecular Cancer Therapeutics, April 2011, American Association for Cancer Research (AACR)

    Phd Giulio Fracasso

  41. SERS labels for quantitative assays: application to the quantification of gold nanoparticles uptaken by macrophage cells

    Article • Analytical Methods, January 2011, Royal Society of Chemistry

    vincenzo Amendola, Phd Giulio Fracasso

  42. Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation

    Article • Journal of Materials Chemistry, January 2011, Royal Society of Chemistry

    stefano agnoli, vincenzo Amendola, Phd Giulio Fracasso

  43. Ribosome-Inactivating Protein-Containing Conjugates for Therapeutic Use

    Article • January 2010, Springer Science + Business Media

    Phd Giulio Fracasso

  44. Correction: The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1

    Article • PLoS ONE, March 2009, PLOS

    Phd Giulio Fracasso

  45. Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes

    Article • Biochemical Journal, January 2008, Portland Press Ltd.

    Phd Giulio Fracasso

  46. N-terminal deletion affects catalytic activity of saporin toxin

    Article • Journal of Cellular Biochemistry, January 2006, Wiley

    Phd Giulio Fracasso

  47. Constitutive Activation of p38 and ERK1/2 MAPKs in Epithelial Cells of Myasthenic Thymus Leads to IL-6 and RANTES Overexpression: Effects on Survival and Migration of Peripheral T and B Cells

    Article • The Journal of Immunology, November 2005, The American Association of Immunologists

    Dr Raffaele Strippoli, Phd Giulio Fracasso

  48. Apical Transport and Folding of Prostate-specific Membrane Antigen Occurs Independent of Glycan Processing

    Article • Journal of Biological Chemistry, October 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Phd Giulio Fracasso

  49. Gangliosides act as onconeural antigens in paraneoplastic neuropathies

    Article • Journal of Neuroimmunology, November 2004, Elsevier

    Phd Giulio Fracasso

  50. Immunotoxins and Other Conjugates: Preparation and General Characteristics

    Article • Mini-Reviews in Medicinal Chemistry, June 2004, Bentham Science Publishers

    Phd Giulio Fracasso

  51. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase

    Article • Biochemical Pharmacology, May 2004, Elsevier

    Professor Rodolfo Ippoliti, Dr Giuseppe Bellisola, Phd Giulio Fracasso

  52. A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin

    Article • Clinical & Experimental Immunology, May 2004, Wiley

    Phd Giulio Fracasso

  53. Anti-tumor effects of toxins targeted to the prostate specific membrane antigen

    Article • The Prostate, August 2002, Wiley

    Phd Giulio Fracasso

  54. Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones

    Article • Clinical & Experimental Immunology, September 2001, Wiley

    Phd Giulio Fracasso

  55. Pharmacokinetics of intrathecal transferrin-ricin A chain immunotoxin

    Article • Life Sciences, June 2001, Elsevier

    Phd Giulio Fracasso

  56. Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies

    Article • Clinical & Experimental Immunology, December 2000, Wiley

    Phd Giulio Fracasso

  57. Effect of therapeutic macromolecules in spheroids

    Article • Critical Reviews in Oncology/Hematology, November 2000, Elsevier

    Phd Giulio Fracasso

  58. Genetic grafting of membrane-acting peptides to the cytotoxin dianthin augments its ability to de-stabilize lipid bilayers and enhances its cytotoxic potential as the component of transferrin-toxin conjugates

    Article • International Journal of Cancer, May 2000, Wiley

    Phd Giulio Fracasso

  59. Improved method for carbohydrate-deficient transferrin determination in human serum by capillary zone electrophoresis

    Article • Journal of Chromatography B Biomedical Sciences and Applications, February 2000, Elsevier

    Phd Giulio Fracasso

  60. Self-potentiation of Ligand-Toxin Conjugates Containing Ricin A Chain Fused with Viral Structures

    Article • Journal of Biological Chemistry, October 1995, American Society for Biochemistry & Molecular Biology (ASBMB)

    Phd Giulio Fracasso

  61. Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin

    Article • British Journal of Cancer, September 1995, Nature

    Phd Giulio Fracasso